TY - JOUR
T1 - Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals
AU - Multi-Drug Resistant Organism Network Investigators Network Investigators and the Antibacterial Resistance Leadership Group
AU - Luterbach, Courtney L.
AU - Chen, Liang
AU - Komarow, Lauren
AU - Ostrowsky, Belinda
AU - Kaye, Keith S.
AU - Hanson, Blake
AU - Arias, Cesar A.
AU - Desai, Samit
AU - Gallagher, Jason C.
AU - Novick, Elizabeth
AU - Pagkalinawan, Stephen
AU - Lautenbach, Ebbing
AU - Wortmann, Glenn
AU - Kalayjian, Robert C.
AU - Eilertson, Brandon
AU - Farrell, John J.
AU - McCarty, Todd
AU - Hill, Carol
AU - Fowler, Vance G.
AU - Kreiswirth, Barry N.
AU - Bonomo, Robert A.
AU - van Duin, David
N1 - Funding Information:
Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the NIH (UM1AI104681 and R21AI114508). Research reported in this publication was also supported by the National Institute of General Medical Sciences (T32GM086330 to C. L. L.) and in part by the NIAID (R01AI143910 to D. v. D.; R01AI090155 and R21AI135250 to B. N. K.; R21AI117338 to L. C. and R01AI100560, R01AI063517, and R01AI072219 to R. A. B.). This study was supported in part by funds or facilities provided by the Cleveland Department of Veterans Affairs to R. A. B. from the Biomedical Laboratory Research and Development, Veterans Affairs Office of Research and Development (1I01BX001974) and the Geriatric Research Education and Clinical Center Veterans Integrated Service Network (VISN) 10 (R. A. B.). K. S. K. is supported by the Division of Microbiology and Infectious Diseases, NIAID and Infectious Diseases (protocol 10–0065 and R01AI119446).
Publisher Copyright:
© 2022 The Author(s).
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: [email protected].
PY - 2023/1/15
Y1 - 2023/1/15
N2 - Background: Carbapenem-resistant Klebsiella pneumoniae (CRKp) is the most prevalent carbapenem-resistant Enterobacterales in the United States. We evaluated CRKp clustering in patients in US hospitals. Methods: From April 2016 to August 2017, 350 patients with clonal group 258 CRKp were enrolled in the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae, a prospective, multicenter, cohort study. A maximum likelihood tree was constructed using RAxML. Static clusters shared ≤21 single-nucleotide polymorphisms (SNP) and a most recent common ancestor. Dynamic clusters incorporated SNP distance, culture timing, and rates of SNP accumulation and transmission using the R program TransCluster. Results: Most patients were admitted from home (n = 150, 43%) or long-term care facilities (n = 115, 33%). Urine (n = 149, 43%) was the most common isolation site. Overall, 55 static and 47 dynamics clusters were identified involving 210 of 350 (60%) and 194 of 350 (55%) patients, respectively. Approximately half of static clusters were identical to dynamic clusters. Static clusters consisted of 33 (60%) intrasystem and 22 (40%) intersystem clusters. Dynamic clusters consisted of 32 (68%) intrasystem and 15 (32%) intersystem clusters and had fewer SNP differences than static clusters (8 vs 9; P =. 045; 95% confidence interval [CI]: -4 to 0). Dynamic intersystem clusters contained more patients than dynamic intrasystem clusters (median [interquartile range], 4 [2, 7] vs 2 [2, 2]; P =. 007; 95% CI: -3 to 0). Conclusions: Widespread intrasystem and intersystem transmission of CRKp was identified in hospitalized US patients. Use of different methods for assessing genetic similarity resulted in only minor differences in interpretation.
AB - Background: Carbapenem-resistant Klebsiella pneumoniae (CRKp) is the most prevalent carbapenem-resistant Enterobacterales in the United States. We evaluated CRKp clustering in patients in US hospitals. Methods: From April 2016 to August 2017, 350 patients with clonal group 258 CRKp were enrolled in the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae, a prospective, multicenter, cohort study. A maximum likelihood tree was constructed using RAxML. Static clusters shared ≤21 single-nucleotide polymorphisms (SNP) and a most recent common ancestor. Dynamic clusters incorporated SNP distance, culture timing, and rates of SNP accumulation and transmission using the R program TransCluster. Results: Most patients were admitted from home (n = 150, 43%) or long-term care facilities (n = 115, 33%). Urine (n = 149, 43%) was the most common isolation site. Overall, 55 static and 47 dynamics clusters were identified involving 210 of 350 (60%) and 194 of 350 (55%) patients, respectively. Approximately half of static clusters were identical to dynamic clusters. Static clusters consisted of 33 (60%) intrasystem and 22 (40%) intersystem clusters. Dynamic clusters consisted of 32 (68%) intrasystem and 15 (32%) intersystem clusters and had fewer SNP differences than static clusters (8 vs 9; P =. 045; 95% confidence interval [CI]: -4 to 0). Dynamic intersystem clusters contained more patients than dynamic intrasystem clusters (median [interquartile range], 4 [2, 7] vs 2 [2, 2]; P =. 007; 95% CI: -3 to 0). Conclusions: Widespread intrasystem and intersystem transmission of CRKp was identified in hospitalized US patients. Use of different methods for assessing genetic similarity resulted in only minor differences in interpretation.
KW - Klebsiella pneumoniae
KW - carbapenem-resistant Enterobacterales
KW - transmission clusters
KW - Carbapenems/pharmacology
KW - Prospective Studies
KW - Humans
KW - Drug Resistance, Bacterial
KW - Klebsiella pneumoniae/genetics
KW - Anti-Bacterial Agents/pharmacology
KW - Klebsiella Infections/epidemiology
KW - Hospitals
KW - Carbapenem-Resistant Enterobacteriaceae/genetics
KW - Cohort Studies
UR - http://www.scopus.com/inward/record.url?scp=85140466192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140466192&partnerID=8YFLogxK
U2 - 10.1093/cid/ciac791
DO - 10.1093/cid/ciac791
M3 - Article
C2 - 36173830
AN - SCOPUS:85140466192
SN - 1058-4838
VL - 76
SP - 229
EP - 237
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 2
ER -